JM Isner, I Baumgartner, G Rauh, R … - Journal of Vascular Surgery, 1998 - Elsevier Purpose: Thromboangiitis obliterans (TAO), or Buerger's disease, a distinct form
of vascular occlusive disease that afflicts the peripheral arteries of young
smokers, is often characterized by an inexorable downhill course even in ... Cited by 271 - Related articles - BL Direct - All 7 versions
[CITATION] Arterial gene therapy for inhibiting restenosis in patients with claudication undergoing …
- ►ahajournals.org PR Vale, DW Losordo, CE Milliken, M Maysky, … - Circulation, 2000 - Am Heart Assoc Methods and Results—A total of 13 consecutive patients (8 men, mean age
60.1±2.3 years) with chronic stable angina due to angiographically documented
coronary artery disease, all of whom had failed conventional therapy ... Cited by 269 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org JR Horowitz, A Rivard, R van der Zee, M … - Arteriosclerosis, thrombosis, and vascular biology, 1997 - Am Heart Assoc Abstract In vitro studies suggest that vascular endothelial growth
factor/vascular permeability factor (VEGF/VPF) may stimulate release of nitric
oxide (NO) from endothelial cells. To investigate the hemodynamic ... Cited by 115 - Related articles - BL Direct - All 5 versions
M Laitinen, J Hartikainen, MO Hiltunen, J … - Human gene therapy, 2000 - liebertonline.com Page 1. HUMAN GENE THERAPY 11:263–270 (January 20, 2000) Mary Ann Liebert, Inc.
Catheter-Mediated Vascular Endothelial Growth Factor Gene ... Cited by 222 - Related articles - BL Direct - All 4 versions
[CITATION] Influence of vascular endothelial growth factor on diabetic retinopathy
- ►ahajournals.org S Rajagopalan, M Shah, A Luciano, R Crystal … - Circulation, 2001 - Am Heart Assoc Methods and Results— Blood flow to the index extremity was measured by
thermodilution at baseline and 30 days after administration of Ad GV VEGF 121.10
, in response to the infusion of endothelium-dependent and -independent ... Cited by 98 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org JM Isner, PR Vale, JF Symes, DW Losordo - Circulation research, 2001 - Am Heart Assoc Clinical trials of cardiovascular gene therapy, whether using viral (53%) or
nonviral (47%) vectors, have thus far disclosed no evidence indicative of
inflammatory or other complications, including death, directly attributable ... Cited by 124 - Related articles - BL Direct - All 5 versions
[CITATION] Constitutive expression of phVEGF 165 following intramuscular gene transfer promotes …
